INTRODUCTION
Oral route of drug admin istration have wide acceptance up to 50-60% of total dosage forms. Solid dosage forms are popular because of ease of administration, accurate dosage, self medication, pain avoidance and most importantly the patient compliance. The most popular dosage forms are being tablet and capsules, one important drawback of these dosage forms for some patients however is the difficu lty in swallowing. 1 Drinking water plays an important role in the swallowing of oral dosage forms. Often times people experience inconvenience in swallo wing conventional dosage forms such as tablet when water is not available in the case of motion sickness (kinetosis) and sudden episodes of coughing during the common cold, allergic conditions and bronchitis. 2 For these reasons, tablet which can rapidly dissolve or disintegrate in the oral cavity have attracted a great deal of attention. Rapidly dissolving or disintegrating tablet are not only indicated for people who have swallo wing difficult ies, but also are ideal for active people. 3 Recently Pharmaceutical industry has become increasingly aware of the need that elderly be considered as a separate and unique medicare population. Though geriatric patients constitute a minor proportion of the population, its growth rate is high and hence will have significant impact on development of drug delivery systems. Thus mouth dissolving tablet are gaining more demand and popularity fro m last few years. 4 Mouth dissolving tablets are those when put on tongue, disintegrates instantaneously, releasing the drug, which dissolves or disperses in the saliva. Faster the drug into solution the quicker the absorption and onset at clinical effect. So me drugs are absorbed fro m the mouth, pharynx and oesophagus as the saliva passes down into the stomach. In such cases, bioavailability of drug is significantly greater than those observed from conventional tablet dosage form. 5 Metoclopramide is chemically related to procainamide. It is a gastric hurrying agent; it is now a widely used antiemet ic. It has more permanent effect on upper G.I.T, increases gastric peristalsis while relaxing the pylorus and the first part of deuodenum. Metoclopramide is an effective antiemetic; acting on the CTZ, blocks apomorphine induced vomiting. Metoclopramide acts through both dopaminerg ic and serotonergic receptors. Metoclopramide is rapidly absorbed orally, enters brain, crosses placenta and is secreted in milk. It is partly conjugated in liver and excreted in urine within 24 hours. Half life of Metoclopramide is 3-6 hours. Orally it acts in 30 m -1 h, but within 10 m after I.M. and 2 m after I.V. injection and lasts upto 4-6 h. It hastens the absorption of many drugs, e.g. Aspirin, Diazepam etc. by facilitating gastric emptying. 6 The principle of the present investigation is to develop and characterize rap idly disintegrating tablets, which disintegrates in the oral cavity in a matter of second without the need of water. This helps in easy swallowing thereby imp roved clin ical effects through pregastric absorption, leading to an increase in bioavailability of the drug and quick onset of pharmacological action can take place.
MATERIALS AND METHODS
Metoclopramide hydrochloride was a gift from Cosme Pharmaceuticals., Goa. Sodiu m Starch Glycolate,
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Microcrystalline cellu lose and L-HPC was a kind gift sample fro m Kawaralal and Co mpany, Mumbai, Reliance Cellu lose Products & Aristo Pharmaceuticals Ltd., and Bhopal respectively. A ll other chemicals purchased from S.D Fine Chemicals, Mumbai, were of analytical reagent grade.
Preparation of Metocl oprami de Hydrochlori de Rapi dly Disintegrating Tablets by Mass Extrusion Techni que
The drug is mixed with powdered Eudragit E-100 in a suitable ratio. Then 10% ethanol is added to the above mixtu re in a glass beaker. The consistency of the above solution is reduced to get gel type of preparation, and then it is extruded through a syringe on clean glass slab. After extrusion of the gel, dried overnight till ethanol is evaporated and solidified material (gel) crushed into granules using a mortar. The granules are passed through a sieve and collected, blend with Avicel PH 102, L-HPC, sodium starch glycolate, lactose, magnesium stearate and talc as in Table 1 . Then b lend is subjected for tablet formulat ion. 
Physical Evaluati on of Metocl oprami de Hydrochlori de Rapi dly Disintegrating Tablets :
The frictional forces in a loose powder or granules can be measured by the angle of repose. This is the maximu m angle possible between the surface of a pile of powder or granules and the horizontal plane. The granules were allo wed to flow through the funnel fixed to a stand at definite height. The angle of repose was then calculated by measuring the height and radius of the heap of granules formed. Percent compressibility of powder mix was determined by Carr's compressibility index calculated by following equation 8 . Carr's Index %= 100 (TBD-LBD)/TBD, where TBD and LBD are the Tapped bulk density and Loosed bulk density respectively. Uncoated tablets were examined under a lens for the shape of the tablet and color was observed by keeping the tablets in light. Three tablets were picked fro m each formulat ion randomly and thickness was measured individually. The tablet thickness was measured using dial-caliper (Mitutoyo, Japan). Hardness indicates the ability of a tablet to withstand mechanical shocks while handling. The hardness of the tablets was determined using Monsanto hardness tester 9 . Three tablets were rando mly picked and hardness of the tablets from each formulation was determined. The friab ility of tablets was determined using Roche Friabilator.
Drug content was calculated by weighing & crushing one tablet.
The whole amount of powdered tablet was transferred into a 100 ml vo lu metric flask. Add 0.1N HCl up to the mark. After few minutes the solution was filtered; rejecting first few ml of the filtrate. 2ml o f filtrate was taken in a 25 ml volumetric flask and diluted up to the mark with 0.1N HCl and analyzed spectrophotometrically at 305 n m.
The concentration of Metoclopramide hydrochloride (in g/ml) was calcu lated by using the standard calibration curve of Metoclopramide hydrochloride. Drug content claim was 10mg per tablet.
This procedure was followed for 5 tablets from each formulat ion.
Following method was applied to measure tablet-wetting time. A piece of tissue paper folded twice was placed in a small petridish (i.d. = 6.5 cm) containing 6 ml of water, a tablet was put on the paper, and the time for co mplete wetting was measured. Three trials for each batch were performed and standard deviation was also determined. A piece of tissue paper folded twice was placed in a s mall Petrid ish containing 6ml of distilled water. A tablet was put on the paper and time required for co mplete wetting was measured. The wetted tablet was then weighed. Water absorption ratio, R, was determined using equation 10 R = 100 x (Wa -Wb)/Wb Where, Wb = weight of the tablet before water absorption and Wa = weight of the tablet after water absorption respectively.
In vitro dispersion time was measured by dropping a tablet in a measuring cylinder containing 6 ml of pH 6.8 (simulated saliva flu id). Three tablets fro m each formulat ion were rando mly selected and in vitro dispersion time was performed.
Standard deviation was also determined and it is exp ressed in seconds 11 .
The process of breakdown of a tablet into smaller particles is called as disintegration. The in vitro disintegration time of a tablet was determined using disintegration test apparatus as per I.P. specificat ions. In vitro release studies were carried out using tablet dissolution test apparatus USP XXIII 12 . The purpose of stability testing is to provide evidence on how the quality of a drug substance or drug product varies with time under the influence of a variety of environmental factors such as temperature, humid ity and light, and enables recommended storage conditions, re-test periods and shelf lives to be established. In the present study, stability studies were carried out at 25 o / 60 % RH and 40 o / 75 % RH for a specific time period up to 30 days for selected formulat ions 13 .
RES ULTS AND DISCUSS ION
The values for angle of repose were found to be in the range of 25 0 .22' to 30 0 .17'. A ll fo rmulat ions showed the angle of repose within 30 0 . This percent compressibility of powder mix was determined by Carr's co mpressibility index. The percent compressibility for all the nine formulat ions lies within the range of 12.676 to 17.808. All formulat ions are showing good compressibility. Rando mly picked tablets from each formulation batch examined under lens for shape and in presence of light for co lor. Tablets showed flat, circu lar shape in wh ite color.
The thickness of the tablets was measured by using dial caliper by picking the tablets randomly. The values are almost uniform in all formu lations. Thickness was found in the range fro m 2.90 mm to 3.18 mm respectively. The results of hardness are given in Table 2 . Hardness test was performed by Monsanto tester. Hardness was maintained to be within 2.90 kg/cm 2 to 4.16 kg/cm 2 , as these tablets are rapidly disintegrating. The lower standard deviation values indicated that the hardness of all the formu lations were almost uniform and possess good mechanical strength with sufficient hardness. The percentage weight variation for all the formulat ion is tabulated in Table 2 . All the tablets passed weight variation test as the % weight variation was within the pharmacopoeial limits of 7.5%. It was found to be from 298.6 to 301.0 mg . The weight of all the tablets was found to be uniform. The content uniformity was performed for all the nine formulat ions and results are shown in Table 2 . Five trials fro m each formulat ion were analyzed spectrophotometrically. The mean value and standard deviation of all the formu lations were calculated. The drug content of the tablets were found between 9.700 0.148 mg to 9.925 0.067 mg of metoclopramide hydrochloride. The results indicated that in all the formu lations the drug content was uniform. The cumu lative percentage drug released by each tablet in the in vitro release studies were based on the mean content of the drug present in the respective tablet.
The internal structure of tablets that is pore size distribution, water penetration into tablets and swelling of disintegration substance are suggested to be the mechanis m of disintegration. This was determined as per I.P. for all the formu lations. All formulat ions showed disintegration time less than 25 seconds. Sodium starch glycolate disintegrates faster (8sec) as compared to other superdisintegrants. Wetting is closely related to inner structure of tablets. The record of the wetting time was shown in Table 3 . The wetting time in all the fo rmulat ion was very fast. This may be due to ability of swelling and also capacity of absorption of water. Sodiu m starch glycolate is having high water absorption capacity and cause swelling. SSG and MCC absorb water rapid ly in the formulat ions and shows fast wetting time. This parameter also duplicates disintegration time in oral cav ity as tablet is kept motionless on tongue; hence correlation between wetting time and disintegration time in oral cavity can also be made. The water absorption ratio results are tabulated in Table  3 The formu lations F3, F6, F9 were selected for stability studies on the basis of their high cumulative % drug release and also results of in vitro disintegration time, wetting time, and in vitro dispersion studies. The stability studies were carried out at 25°/ 60% RH and 40°/ 75% RH for all the selected formu lations up to 30 days. For every 10 d time interval the tablets were analyzed for drug content uniformity, hardness, in vitro disintegration time, friability and wetting time up to 30 d. These formu lations showed not much variation in any parameter. Fro m these results it was revealed that, formulat ions F3, F6, F9 are stable and retained their original properties.
